Skip to content
Search

Latest Stories

Health Minister lauds programme preparing future pharmacists for prescribing roles

Health Minister lauds programme preparing future pharmacists for prescribing roles

Mike Nesbitt believes that optimising pharmacists' skills can help strengthen the HSC workforce and alleviate pressures in healthcare

Northern Ireland’s Health Minister, Mike Nesbitt, has welcomed the launch of the 2024/25 Experiential Learning (EL) Programme, designed to equip future pharmacists with the skills needed for a greater role in clinical care.

Starting in 2026, pharmacy undergraduate students will qualify as independent prescribers upon registration, and this programme is designed to prepare them for that responsibility.


The EL Programme provides pharmacy students with multi-sector clinical work placements across the region.

Speaking at the programme's launch at Ulster Hospital, Minister Nesbitt said: “This is the second year of this successful programme, which will see pharmacy students in Northern Ireland benefit from the training by completing up to twelve weeks of practice-based learning in hospitals, community pharmacies and general practices across NI.

“This will provide them with actual practice-based experiences in a range of healthcare settings, facilitating them to interact with patients and engage in interprofessional practice.

He emphasised the importance of optimising the skills of pharmacist independent prescribers, noting that this could enhance the capability and capacity of the Health and Social Care (HSC) workforce, helping to ease pressures in areas such as primary, secondary and emergency care.

“Widening access to care can also assist in tackling health inequalities,” the minister said, expressing his enthusiasm to seeing the potential benefits for graduates, the HSC and patients.

Chief pharmaceutical officer Professor Cathy Harrison described EL as “an essential component within the initial education and training of pharmacy professionals.”

“Utilising pharmacists’ skills as patient-facing clinical specialists in medicines can help ensure that patients get safe, effective, and right medicines,” she said.

She commended the programme's growth and acknowledged the contributions of the “experienced and committed” network of hospital Trust Clinical Education and Practice Supervisor pharmacists, along with over 270 community pharmacists and 115 general practice pharmacists, who are providing EL practice supervisor training, supporting student learning in primary care.

Professor Harrison extended her best wishes to all pharmacy students who are completing their EL placements this year, as well as to the Northern Ireland Centre for Pharmacy Learning and Development (NICPLD), universities, hospitals, community pharmacies, general practices, and all stakeholders for their “continued hard work and collaboration in helping to make the programme a continued success.”

The NICPLD, based at Queen’s University Belfast (QUB), has been commissioned by the Department of Health to design, manage, and deliver the EL Programme. It works with QUB, Ulster University (UU), Community Pharmacy NI (CPNI), GP Federations, hospitals, and local employers to coordinate student placements.

The EL Programme was developed to align with new mandatory initial education and training (IET) reforms and standards for pharmacists in Northern Ireland, jointly developed by the General Pharmaceutical Council (GPhC) and the Pharmaceutical Society of Northern Ireland (PSNI).

To meet the new standards, periods of EL or practice-based learning are now integrated into the MPharm degree, allowing students to complete up to 12 weeks of placements in both primary and secondary care throughout the course.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less